英文互译镜像站

N-sec-Butyltryptamine

Last updated

N-sec-Butyltryptamine
NSBT structure.png
NsBT 3D.png
Clinical data
Other namesNsBT; NSBT
Routes of
administration
Oral [1] [2]
Drug class Psychoactive drug [1] [2]
ATC code
  • None
Pharmacokinetic data
Duration of action "Short" [1]
Identifiers
  • N-[2-(1H-indol-3-yl)ethyl]butan-2-amine
PubChem CID
ChemSpider
Chemical and physical data
Formula C14H20N2
Molar mass 216.328 g·mol−1
3D model (JSmol)
  • CCC(C)NCCC1=CNC2=CC=CC=C21
  • InChI=1S/C14H20N2/c1-3-11(2)15-9-8-12-10-16-14-7-5-4-6-13(12)14/h4-7,10-11,15-16H,3,8-9H2,1-2H3
  • Key:WDWNZOAFDWLAGZ-UHFFFAOYSA-N

N-sec-Butyltryptamine (NsBT) is a psychoactive drug of the tryptamine family related to psychedelics like dimethyltryptamine (DMT). [1] [2]

Contents

Use and effects

NsBT was briefly described by Alexander Shulgin in his 1997 book TiHKAL (Tryptamines I Have Known and Loved). [1] According to Shulgin, NsBT is active at a dose of 25 to 75 mg orally and has a short-lived duration. [1] [2] Its effects included a generalized and somewhat diffuse intoxication, intellectual excitement, modest sensory enhancements, and "a lot of erotic horniness". [1] However, no "plus-three" ratings occurred on the Shulgin Rating Scale. [1]

Shulgin has said that along with N-tert-butyltryptamine (NtBT), it is one of only two N-mono-substituted tryptamines with known psychoactivity. [1] He also said that N-mono-substituted tryptamines might be GHB-like intoxicants devoid of psychedelic effects. [1] However, N-methyltryptamine (NMT) has been reported to produce psychedelic effects. [1] [3] [4]

Chemistry

Analogues

Analogues of NsBT include N-methyltryptamine (NMT), N-ethyltryptamine (NET), N-isopropyltryptamine (NiPT), N-benzyltryptamine (NBnT), and N-methyl-N-sec-butyltryptamine (MsBT), among others. [1]

Society and culture

Canada

NsBT is not a controlled substance in Canada as of 2025. [5]

See also

References

  1. 1 2 3 4 5 6 7 8 9 10 11 12 Shulgin A, Shulgin A (September 1997). TiHKAL: The Continuation. Berkeley, California: Transform Press. ISBN   0-9630096-9-9. OCLC   38503252. https://erowid.org/library/books_online/tihkal/tihkal49.shtml "The two geometric isomers, mono-isobutyl and mono-sec-butyl tryptamines are best called NIBT and NSBT. They also have been made by the oxalylamide route and the hydrochloride salts melt at 150-151 °C and 175-177 °C resp. Interestingly, NSBT is one of the two mono-substituted tryptamines that just might have CNS activity. It has shown a generalized and somewhat diffuse intoxication with several studies covering the 25 to 75 milligram range. Short lived, intellectual excitement with some modest sensory enhancements. Promising, and a lot of erotic horniness, but no plus threes, yet." [...] "The tertiary-butyl analogue, NTBT, is the remaining mono-substituted tryptamine that just might have psychotropic potential. In the 5 to 20 milligram area, there is a light-headed intoxication that is a totally pleasant buzz, but nothing more profound than that. Wouldn't it be fascination of it turned out that all of the mono-tryptamines (the NRT's) were GHB-like intoxicants, and totally devoid of psychedelic activity. That would be a true challenge to the SAR crowd. I was told many years ago that NTBT was extremely potent when smoked, but I never received any particulars, and I must leave that as a baseless rumor."
  2. 1 2 3 4 Shulgin AT (2003). "Basic Pharmacology and Effects". In Laing RR (ed.). Hallucinogens: A Forensic Drug Handbook. Forensic Drug Handbook Series. Elsevier Science. pp. 67–137. ISBN   978-0-12-433951-4.
  3. Nen (4 December 2011). Entheogenic effects of NMT from Acacia. Entheogenesis Australis (EGA) Conference, Victoria, Australia, 2–5 December 2011 (PDF). Archived from the original on 5 April 2025. Retrieved 15 April 2025.{{cite conference}}: CS1 maint: bot: original URL status unknown (link)
  4. Nen (13 July 2013). NMT: A Spatial Hallucinogen With Therapeutic Applications. Breaking Convention: The Second Multidisciplinary Conference on Psychedelic Consciousness, University of Greenwich, London, 12–14 July 2013.
  5. "Controlled Drugs and Substances Act". Department of Justice Canada. Retrieved 19 January 2026.
网站克隆 百变TDK镜像 百变TDK镜像 镜像站群系统 镜像站群